ID THIM_CLOPS Reviewed; 265 AA. AC Q0STA0; DT 15-JAN-2008, integrated into UniProtKB/Swiss-Prot. DT 05-SEP-2006, sequence version 1. DT 16-JUN-2009, entry version 22. DE RecName: Full=Hydroxyethylthiazole kinase; DE EC=2.7.1.50; DE AltName: Full=4-methyl-5-beta-hydroxyethylthiazole kinase; DE Short=Thz kinase; DE Short=TH kinase; GN Name=thiM; OrderedLocusNames=CPR_1337; OS Clostridium perfringens (strain SM101 / Type A). OC Bacteria; Firmicutes; Clostridia; Clostridiales; Clostridiaceae; OC Clostridium. OX NCBI_TaxID=289380; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16825665; DOI=10.1101/gr.5238106; RA Myers G.S.A., Rasko D.A., Cheung J.K., Ravel J., Seshadri R., RA DeBoy R.T., Ren Q., Varga J., Awad M.M., Brinkac L.M., Daugherty S.C., RA Haft D.H., Dodson R.J., Madupu R., Nelson W.C., Rosovitz M.J., RA Sullivan S.A., Khouri H., Dimitrov G.I., Watkins K.L., Mulligan S., RA Benton J., Radune D., Fisher D.J., Atkins H.S., Hiscox T., Jost B.H., RA Billington S.J., Songer J.G., McClane B.A., Titball R.W., Rood J.I., RA Melville S.B., Paulsen I.T.; RT "Skewed genomic variability in strains of the toxigenic bacterial RT pathogen, Clostridium perfringens."; RL Genome Res. 16:1031-1040(2006). CC -!- CATALYTIC ACTIVITY: ATP + 4-methyl-5-(2-hydroxyethyl)thiazole = CC ADP + 4-methyl-5-(2-phosphonooxyethyl)thiazole. CC -!- PATHWAY: Cofactor biosynthesis; thiamine pyrophosphate CC biosynthesis; 4-methyl-5-(2-phosphoethyl)-thiazole from 4-methyl- CC 5-(2-hydroxyethyl)-thiazole: step 1/1. CC -!- SIMILARITY: Belongs to the Thz kinase family. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; CP000312; ABG86073.1; -; Genomic_DNA. DR RefSeq; YP_698657.1; -. DR GeneID; 4205487; -. DR GenomeReviews; CP000312_GR; CPR_1337. DR KEGG; cpr:CPR_1337; -. DR TIGR; CPR_1337; -. DR HOGENOM; Q0STA0; -. DR OMA; Q0STA0; ASPVMAH. DR GO; GO:0005524; F:ATP binding; IEA:HAMAP. DR GO; GO:0004417; F:hydroxyethylthiazole kinase activity; IEA:HAMAP. DR GO; GO:0009228; P:thiamin biosynthetic process; IEA:UniProtKB-KW. DR HAMAP; MF_00228; -; 1. DR InterPro; IPR000417; Hyethyz_kinase. DR InterPro; IPR011144; Hyethyz_kinsmonf. DR PANTHER; PTHR20857:SF14; Hyethyz_kinase; 1. DR Pfam; PF02110; HK; 1. DR PIRSF; PIRSF000513; Thz_kinase; 1. DR PRINTS; PR01099; HYETHTZKNASE. PE 3: Inferred from homology; KW ATP-binding; Complete proteome; Kinase; Nucleotide-binding; KW Thiamine biosynthesis; Transferase. FT CHAIN 1 265 Hydroxyethylthiazole kinase. FT /FTId=PRO_1000021506. FT BINDING 36 36 Substrate; via amide nitrogen (By FT similarity). FT BINDING 112 112 ATP (By similarity). FT BINDING 160 160 ATP (By similarity). FT BINDING 187 187 Substrate; via amide nitrogen (By FT similarity). SQ SEQUENCE 265 AA; 29595 MW; C60CCC5533A51D02 CRC64; MEVLKRENPL IHMITNYVTV NDLAQVTINY GGLPLMATHH DELKVITKMA NGLLVNIGTL EPYQMESSMI SMKIAKEKGI PSVLDSVCVQ VSKLRRDFAK KIILEGEPSL IKGNLAEIKT LIGETSNSIG IDSFEDSLSE NTKNKIKEYA KERNLIVVVS GVVDFITNGE ESASVKNGTY KMSKITGTGC MLGALLTLAL SFYDHKDLRF KEVVKAVSTW GICGELAEER LREKEGLMTF KYNLLDELSI INDEIIKERE KVIYE //